The companies that survive will look less like pyramids and more like swarms: small, autonomous AI-first pods that move and ...
Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Strong financial position with cash, cash equivalents and short-term investments of $786.5 million as of June 30, 2025 expected to fund projected operations and key clinical milestones through at ...
The Department of Homeland Security announced Thursday it will resume issuing travel authorization to migrants from Cuba, Haiti, Nicaragua and Venezuela who apply to come to the United States with the ...
WASHINGTON, D.C. -- The Medical Strategic Leadership Program (MSLP) is an initiative by the U.S. Army Surgeon General, designed to provide strategic-level training to military medical leaders from ...
Learning to program in C on an online platform can provide structured learning and a certification to show along with your resume. Looking into learning C, one of the most popular programming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback